AI

  • Generative AI used to create translatable paediatric care videos for LMIC hospitals

    A team of US researchers has turned to generative AI to tackle problems plaguing child medical care delivery in resource-poor countries that increase risk for poor outcomes and mortality. The clinicians developed a series of 45 multilingual videos, each ranging from three to eight minutes long, designed to educate providers around the world on paediatric [...]

  • Aim AI policies at hardware to ensure safety, experts say

    A global registry tracking the flow of chips destined for AI supercomputers is one of the policy options highlighted by a major new report calling for regulation of 'compute' – the hardware that underpins all AI – to help prevent AI misuse and disasters. Other technical proposals presented by the report include 'compute caps' – [...]

  • Listen: Sound – a game-changing tool for holistic health monitoring?

    Decorte Future Industries uses AI to extract health data from sound.  In the new episode of the Health Tech World Podcast, we speak to founder Dr Roeland Decorte about his vision to provide an ongoing, holistic view of a user’s physical and mental condition, including the tracking of potential cardiovascular, respiratory, neurological and mental wellbeing issues. Listen now on Spotify or [...]

  • AI-powered personalised medicine project launches in UK and EU

    An innovative project using AI to personalise therapies for patients with cardiovascular disease has been launched in the UK and EU. The NextGen project has received €7.6 million (£6.4 million) from the EU’s Horizon Europe programme and will be delivered by a 21-member consortium, including the European Society of Cardiology. Cardiovascular diseases (CVDs) are the [...]

  • AI helps to predict whether antidepressants will work

    Researchers in the Netherlands have harnessed AI to successfully predict within a week whether an antidepressant would work in patients with major depresssive disorder (MDD). Using an AI algorithm, a brain scan and an individual's clinical information, the team from Amsterdam UMC and Radboudumc could see up to eight weeks faster whether or not the [...]

  • £12m research hub set to accelerate AI in the UK

    A £12 million UK research hub will develop state-of-the-art AI for chemistry and accelerate its adoption, following a combined investment from the Engineering & Physical Sciences Research Council (EPSRC) and consortium partners. The AI for Chemistry Hub or AlChemy will bring together leading academic researchers, industry and other stakeholders to promote a collaborative community, offer [...]

  • ICO seeks permission to appeal Clearview AI Inc’s successful challenge

    By Pilar Arzuaga, Senior Associate, Jonathan Robb, Senior Associate and Jack Thorne, Partner, McDermott Will & Emery

  • AI harnesses tumour genetics to predict treatment response

    Researchers at University of California San Diego School of Medicine leveraged a machine learning (ML) algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy. All cells, including cancer cells, rely on complex molecular machinery to replicate DNA as part of the normal cell division process. Most chemotherapies [...]

  • UK AI project aims to make international health data sharing easier

    A British University is to explore the use of AI to improve sharing health data internationally as part of a European-wide project. Called BETTER (Better real-world health data distributed analytics research platform) project the spans 16 academic, medical and industrial partners, with Aston University awarded €317,500 (£272,600) for its contribution. While data-driven medicine is currently [...]

  • Machine learning predicts response to arthritis drug in children

    Doctors may one day be able to target children and young people with arthritis most likely to be helped by its first-line treatment, thanks to the application of machine learning by University of Manchester scientists. Methotrexate is the first-line drug to be given for Juvenile idiopathic arthritis (JIA) but it is only effective or tolerated [...]